NSC |
Compound |
Enrichment |
Correlation |
NSC 651855 |
Null |
0.0108954273764103 |
-0.026905152 |
NSC 655901 |
ANTINEOPLASTIC-655901 |
0.0108954273764103 |
0.25003912 |
NSC 65628 |
Null |
0.0108954273764103 |
0.31090081 |
NSC 670226 |
trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid |
0.0108954273764103 |
0.13148712 |
NSC 670789 |
9-[(Z)-Bromoiodomethylidene]-9,10-dihydrophenanthrene-10-one |
0.0108954273764103 |
0.42791636 |
NSC 672116 |
9-.alpha.-Acetoxyparthenolide |
0.0108954273764103 |
0.49574701 |
NSC 673141 |
Null |
0.0108954273764103 |
0.53216447 |
NSC 677696 |
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester |
0.0108954273764103 |
0.56522167 |
NSC 700455 |
Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- |
0.0108954273764103 |
0.51915324 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0108954273764103 |
0.28454179 |